Preview

Osteoporosis and Bone Diseases

Advanced search

BONE AND METABOLIC CONTROL

https://doi.org/10.14341/osteo2016112-13

About the Author

Nicolas Bonnet
Geneva University Hospital & Faculty of Medicine
Division of Bone Diseases, Department of Internal Medicine Specialties


References

1. Karsenty G, Ferron M. The contribution of bone to whole-organism physiology. Nature. 2012;481(7381):314-20

2. Ferrari S. Diabetes and osteoporosis. Rev Med Suisse. 2013;9(390):1258-9.

3. Gullberg B, Johnell O, Kanis JA. Worldwide projections for hip fracture. Osteoporosis Int. 1997;7:407-13.

4. Hita-Contreras F, Martlnez-Amat A, Cruz-Diaz D, Pérez-Lopez FR. Osteosarcopenic obesity and fall prevention strategies. Maturitas. 2015;80(2):126-32.

5. Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, Wan C, Chen D, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell. 2010;142(2):309-19.

6. Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 2012;50(2):568-75.

7. Wei J, Ferron M, Clarke CJ, Hannun YA, Jiang H, Blaner WS, et al. Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J Clin Invest. 2014;124(4):1-13.


Review

For citations:


Bonnet N. BONE AND METABOLIC CONTROL. Osteoporosis and Bone Diseases. 2016;19(1):12-13. (In Russ.) https://doi.org/10.14341/osteo2016112-13

Views: 488


ISSN 2072-2680 (Print)
ISSN 2311-0716 (Online)